The urinary phosphate to serum fibroblast growth factor 23 ratio is a useful marker of atherosclerosis in early-stage chronic kidney disease

Hodaka Yamada, Makoto Kuro-o, Kazuo Hara, Yuichiro Ueda, Ikuyo Kusaka, Masafumi Kakei, San E. Ishikawa

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'The urinary phosphate to serum fibroblast growth factor 23 ratio is a useful marker of atherosclerosis in early-stage chronic kidney disease'. Together they form a unique fingerprint.

Medicine & Life Sciences